Athlete’s foot (Tinea pedis) is a fungal infection, caused by
different types of fungi including Trichophyton, Epidermophyton, and
Microsporum. The athlete's foot fungus attacks the keratin rich
tissues such as skin, nail, and hair. These fungus dwell there
because these have enzymatic ability to decompose keratin. Keratin is
a fibrous structural protein that is primarily found in nail, hair,
and outer layers of human skin. Moreover, these fungus need warm and
moist environment for survival and growth. These are commonly found
in shower areas of swimming pools and gym. Athlete’s foot is a
contagious disease, which can easily spread through contact with
infected individuals. Common symptoms of tinea pedis are itching, red
blisters between the toes or on the sole, and dry flaky skin on the
feet.
Request Brochure for Detailed Analysis @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=43694
Athlete’s foot infection can be diagnosed by detecting the disease
symptoms, clinical testing, and a skin lesion potassium hydroxide
(KOH) examination. Potassium hydroxide (KOH) examination is the most
common test for athlete’s foot. Potassium hydroxide (KOH) destroys
the normal cells and leaves the fungal cells undamaged, so that these
are easily observed under a microscope. Prevalence of athlete’s
foot is higher among in men because they are more exposed to nail
trauma due to usage of occlusive footwear. Presently, athlete’s
foot affects over 15% of the global population. Athlete’s foot is
often treated with over-the-counter (OTC) antifungal medications such
as miconazole, terbinafine, clotrimazole, tolnaftate, and butenafine.
In March 1999, terbinafine hydrochloride (Lamisil) was the first drug
approved for athlete’s foot treatment.
Increase in awareness about fungal infections and rise in incidence
of such infections across the world are projected to drive the global
athlete’s foot (tinea pedis) treatment market during the forecast
period. Additionally, continuously increasing unhygienic environment
in populated cities of the world and popularity of over-the-counter
antifungal drugs for dermal infection are anticipated to drive the
global athlete’s foot (tinea pedis) treatment market in the near
future. However, side effects of antifungal drugs such as allergic
reactions over the skin, liver damage, and increase in resistance
developed by fungi are likely to restrain the global athlete’s foot
(tinea pedis) treatment market.
Enquire for Discount @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=43694
The global athlete’s foot (tinea pedis) treatment market can be
segmented based on drug class, route of administration, distribution
channel, and region. In terms of drug class, the global market can be
categorized into antifungals antibiotics, steroids, and others. Based
on route of administration, the global athlete’s foot (tinea pedis)
treatment market can be bifurcated into topical antifungals and oral
antifungals. In terms of distribution channel, the global market can
be divided into online pharmacies, retail pharmacies, and hospital
pharmacies.
Geographically, the global athlete’s foot (tinea pedis) treatment
market can be segmented into North America, Europe, Latin America,
Asia Pacific, and Middle East & Africa. North America is expected
to account for the largest share of the global market because of
major players concentrated in the U.S. resulting in extensive
research and development for developing better drugs. Europe is
expected to be the second largest market for athlete’s foot (tinea
pedis) treatment during the forecast period, due to rise in
prevalence of fungal infection and increase in awareness about new
treatment options. The athlete’s foot (tinea pedis) treatment
market in Asia Pacific is expected to expand rapidly during the
forecast period. Growth of the market in the region can be attributed
to increase in awareness about personal hygiene and better access to
health care.
Request TOC of the Report for Complete Review @
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=43694
Key players operating in the global athlete’s foot (tinea pedis)
treatment market are Valeant Pharmaceuticals, Quinnova
Pharmaceuticals, Inc., Anacor Pharmaceuticals, Inc., Cardinal Health,
Novartis AG, Merck & Co, Inc., Bayer Healthcare LLC, Janssen
Pharmaceuticals, Inc., Pfizer, Inc., Medimetriks Pharmaceuticals,
Inc., Medicis Pharmaceutical Corporation, and Johnson and Johnson
Healthcare.
About Us
Transparency Market Research is a next-generation market intelligence
provider, offering fact-based solutions to business leaders,
consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow,
evolve, and mature. Our real-time data collection methods along with
ability to track more than one million high growth niche products are
aligned with your aims. The detailed and proprietary statistical
models used by our analysts offer insights for making right decision
in the shortest span of time. For organizations that require specific
but comprehensive information we offer customized solutions through
adhoc reports. These requests are delivered with the perfect
combination of right sense of fact-oriented problem solving
methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems
with right methodology of research is the key to help enterprises
reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
